Clinical Trial Update: A Study to Assess the Efficacy and Safety of ETC-1002 in Subjects With Elevated Blood Cholesterol and Either Normal or Elevated Triglycerides [Phase 2]

View source ↗

Summary

Phase 2 trial update for ETC-1002 evaluating efficacy and safety in dyslipidemia with variable triglyceride levels; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia

Drugs mentioned

• ETC-1002 (bempedoic acid)

Snippet

Sponsor: Esperion Therapeutics, Inc. | Conditions: Dyslipidemia | Phase 2 | Status: COMPLETED | Results posted: 2021-03-16